farnesol has been researched along with Cancer of Skin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alam, MS; Athar, M; Chaudhary, SC; Siddiqui, MS | 1 |
Eisen, TG; Smalley, KS | 1 |
Halaschek-Wiener, J; Heere-Ress, E; Jansen, B; Kloog, Y; Marciano, D; Moll, I; Pehamberger, H; Schlagbauer-Wadl, H; Waltering, S; Wolff, K | 1 |
3 other study(ies) available for farnesol and Cancer of Skin
Article | Year |
---|---|
Chemopreventive effect of farnesol on DMBA/TPA-induced skin tumorigenesis: involvement of inflammation, Ras-ERK pathway and apoptosis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Apoptosis; Chemoprevention; Cyclooxygenase 2; Disease Models, Animal; Drug Screening Assays, Antitumor; Extracellular Signal-Regulated MAP Kinases; Farnesol; Inflammation; Mice; Ornithine Decarboxylase; Oxidative Stress; ras Proteins; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate | 2009 |
Farnesyl transferase inhibitor SCH66336 is cytostatic, pro-apoptotic and enhances chemosensitivity to cisplatin in melanoma cells.
Topics: 3T3 Cells; Actins; Alkyl and Aryl Transferases; Animals; Apoptosis; Blotting, Western; Cell Cycle; Cell Division; Cisplatin; Colony-Forming Units Assay; Drug Synergism; Enzyme Inhibitors; Farnesol; Farnesyltranstransferase; Humans; In Situ Nick-End Labeling; In Vitro Techniques; Melanoma; Mice; Microscopy, Confocal; Mitogen-Activated Protein Kinases; Piperidines; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyridines; Retinoblastoma Protein; Salicylates; Skin Neoplasms; Tumor Cells, Cultured | 2003 |
Farnesylthiosalicylic acid inhibits the growth of human Merkel cell carcinoma in SCID mice.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Merkel Cell; Cell Division; Farnesol; Female; Humans; Injections, Intraperitoneal; Male; Mice; Mice, SCID; Proto-Oncogene Proteins p21(ras); Salicylates; Skin Neoplasms; Statistics, Nonparametric; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1999 |